TNF Inhibitor for Gastrointestinal Disease Treatment, EP3810095A1

Fri, 17 Apr 2026 03:27:33 +0000
Intellectual Property

The EPO published patent application EP3810095A1 for BT Bidco, Inc., covering a TNF inhibitor formulation for treating gastrointestinal diseases. The patent application was published under IPC classifications A61K 9/22, A61K 31/436, and A61K 48/00. The application designates all EU member states plus other EPC contracting states including CH, GB, LI, MC, NO, TR, and IS.